Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions.

de Vries, Rory Dvan der Heiden, MariekeGeers, DarylImhof, Celinevan Baarle, Debbie2021-12-232021-12-233490791610.1172/JCI155499http://hdl.handle.net/10029/625448enAdaptive immunityImmunologyT cellsVirologyDifference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions.Article1558-8238J Clin Invest 2021;131(24):e155499